In Brief: Excedrin labeling

Excedrin labeling: Aspirin reference on front panel of Bristol-Myers' Excedrin Extra Strength tablets appears "in very small print, which may not be easily seen by people in a hurry or those with poor eyesight," the Institute for Safe Medication Practices points out in its July 30 "Medication Safety Alert." The alert mentions the recent FDA advisory committee decision to recommend Excedrin Extra Strength for use as a migraine treatment, noting that, if approved, Excedrin likely will be widely used by the estimated 23 mil. migraine sufferers in the U.S. ("The Tan Sheet" July 21, pp. 8-12). "Patient education will help, but improved labeling and label warnings would facilitate this awareness," ISMP suggests...